BioSpace News Archive

Business

Premier Biomedical’s CEO, William A. Hartman, Returns to Uptick Network “Stock Day” for an Update on Latest Company Developments

Mr. Hartman overviewed the Company’s Anti-Cancer R&D program and discussed his intent to find a licensee for the technology or investment partner to complete the development of this very promising anti-cancer antibody drug.

November 20, 2017

·

3 min read

TiGenix to Present Positive 52-Week Phase III Cx601 Data at EHA-SWG Scientific Meeting

Phase III clinical trial of Cx601 for the treatment of complex perianal fistulas in patients with Crohn’s disease will be presented at the EHA-SWG Scientific Meeting on Shaping the Future of Mesenchymal Stromal Cells Therapy taking place from November 23-25, 2017 in Amsterdam, Netherlands.

November 20, 2017

·

4 min read

Drug Development

Galapagos NV: ALBATROSS With GLPG2222 Shows Positive Clinical Results in CF Patients

The ALBATROSS study included 37 cystic fibrosis patients with a gating (Class III) mutation on one allele and F508del (Class II) mutation on the other allele.

November 20, 2017

·

6 min read

Business

bionorthTX’s iC3 Summit Grows Popular Hub in North Texas for Life Sciences Companies

The North Texas region has become a popular destination for Life Sciences companies

November 20, 2017

·

3 min read

Business

Biostar Pharma Announces its Quarterly Results for Nine Months Ended September 30, 2017

The Company had no sales on all Aoxing Pharmaceutical products in the third fiscal quarter ended September 30, 2017 as Aoxing Pharmaceutical temporarily stopped production to conduct maintenance of its production lines to renew its GMP certificates.

November 20, 2017

·

20 min read

Business

China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2018

Revenues for the second quarter of fiscal 2018 increased by 27.4% to RMB234.6 million from RMB184.1 million in the prior year period.

November 20, 2017

·

37 min read

Drug Development

Revance Announces Orphan Drug Designation of RT002 for the Treatment of Cervical Dystonia

The FDA Office of Orphan Products Development grants orphan designation to drugs and biologics intended for treatment of rare diseases or conditions that affect fewer than 200,000 people in the U.S.

November 20, 2017

·

6 min read

Lone Star Bio

New Study Proves 2-Minute Cycle With Pulsed Xenon UV Significantly Reduces OR Contamination

The Xenex robot eliminated 72% more Pathogens than manual cleaning alone.

November 20, 2017

·

3 min read

Business

Varian Announces Opening of New Facility in Brazil

In 2018 the manufacturing and warehousing areas of the facility will become operational.